Access to anti-retroviral drugs, female in Euro area
Euro area: Access to anti-retroviral drugs, female was 88.6% in 2022. ▲ Rising
Access to anti-retroviral drugs, female in Euro area, 2000–2022
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in Euro area is 88.6%, measured in 2022. That is the highest value across all 23 years on record.
Compared with earlier readings it is up 1.5% on the previous year and up 12.5% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Euro area peaked at 88.6% in 2022 and was at its lowest, 42.0%, in 2000.
The long-run direction has been consistently rising across the 23 years of available data.
Access to anti-retroviral drugs, female in Euro area, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 42.0% | — |
| 2001 | 46.9% | +11.7% |
| 2002 | 51.1% | +8.9% |
| 2003 | 55.3% | +8.3% |
| 2004 | 59.0% | +6.6% |
| 2005 | 62.6% | +6.2% |
| 2006 | 65.7% | +4.9% |
| 2007 | 68.0% | +3.6% |
| 2008 | 70.2% | +3.2% |
| 2009 | 72.9% | +3.8% |
| 2010 | 74.6% | +2.3% |
| 2011 | 76.6% | +2.6% |
| 2012 | 78.8% | +2.9% |
| 2013 | 79.9% | +1.4% |
| 2014 | 80.4% | +0.6% |
| 2015 | 82.1% | +2.1% |
| 2016 | 82.9% | +1.0% |
| 2017 | 85.9% | +3.6% |
| 2018 | 85.8% | -0.1% |
| 2019 | 86.8% | +1.1% |
| 2020 | 86.7% | -0.1% |
| 2021 | 87.2% | +0.7% |
| 2022 | 88.6% | +1.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 59.4% | 42.0% | 72.9% | 10 |
| 2010s | 81.4% | 74.6% | 86.8% | 10 |
| 2020s | 87.5% | 86.7% | 88.6% | 3 |
Countries ranked near Euro area
More gender data for Euro area
- Labor force, female 81.83 million (2025)
- Labor force, female, per capita 0.2281 units per person (2025)
- Labor force, female, per unit of GDP 0 units per US$ of GDP (2025)
- Labor force, female, annual growth rate -0.0473 % change on previous year (2025)
- Labor force, female, per square kilometre 28.76 units per square kilometre (2023)
- Incidence of HIV, ages 15-49, female 0.0959 per 1,000 uninfected female population ages 15-49 (2024)
- Incidence of HIV, ages 15-49, male 0.1756 per 1,000 uninfected male population ages 15-49 (2024)
- Ratio of female to male youth unemployment rate (% ages 15-24) 97.9% (2025)
- School life expectancy, primary to tertiary, female 17.23 years (2019)
- School life expectancy, primary to tertiary, male 16.65 years (2019)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Euro area?
- Access to anti-retroviral drugs, female in Euro area was 88.6% in 2022, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Euro area?
- The highest recorded value was 88.6% in 2022.
- What is the lowest access to anti-retroviral drugs, female recorded in Euro area?
- The lowest recorded value was 42.0% in 2000.
- How does Euro area rank for access to anti-retroviral drugs, female?
- Euro area ranks 2nd out of 19 groups with data for 2022.
- Is access to anti-retroviral drugs, female rising or falling in Euro area?
- Over the last ten years it is up 12.5%. The long-run trend across the full record is rising.
- Where does this Euro area data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 23 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.